Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting

被引：0
|
作者：
Sands, Bruce [1 ]
Khalid, Javaria [2 ]
Barocas, Morris [3 ]
Raluy-Callado, Mireia [4 ]
Merinopoulou, Evie [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Takeda Dev Ctr Europe Ltd, London, England
[3] Takeda Pharmaceut Inc, Deerfield, IL USA
[4] Evidera, London, England
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-064
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [21] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    GASTROENTEROLOGY, 2018, 154 (01) : S105 - S106
  • [22] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [23] Characteristics of Patients With Ulcerative Colitis Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufi L.
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S825 - S825
  • [24] Efficacy of Vedolizumab With Concomitant Corticosteroid or Immunomodulator Use in Patients With Crohn's Disease From GEMINI 2
    Colombel, Jean-Frederic
    Loftus, Edward V.
    Siegel, Corey A.
    Lewis, James
    Smyth, Michael D.
    Xu, Jing
    Abhyankar, Brihad
    GASTROENTEROLOGY, 2015, 148 (04) : S277 - S277
  • [25] Efficacy of Ustekinumab and Vedolizumab Among Postoperative Crohn's Disease Patients as Postoperative Prophylaxis and Rescue Therapy: Real-world Data
    Ertem, Furkan U.
    Rivers, Claudia Ramos
    Ghaffari, Amir Ali
    Watson, Andrew R.
    Tang, Gong
    Schwartz, Marc
    Johnston, Elyse
    Barrie, Arthur
    Harrison, Janet
    Dueker, Jeffrey M.
    Hartman, Doug
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2024, 31 (02) : 461 - 466
  • [26] Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States
    Chiorean, Michael
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Guerin, Annie
    Fan, Tao
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 877 - 885
  • [27] Vedolizumab Outcomes in Real-world Bio-naive Ulcerative Colitis and Crohn's Disease Patients (EVOLVE) in North America
    Yarur, Andres
    Bassel, Marielle
    Stein, Dara
    Kim, Hankyul
    Radulescu, Gabriela
    Lopez, Claudia
    Lissoos, Trevor
    Demuth, Dirk
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S374 - S374
  • [28] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Braunstahl, Gert-Jan
    Chlumsky, Jan
    Peachey, Guy
    Chen, Chien-Wei
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [29] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Gert-Jan Braunstahl
    Jan Chlumský
    Guy Peachey
    Chien-Wei Chen
    Allergy, Asthma & Clinical Immunology, 9
  • [30] Assessment of real-world effectiveness of risankizumab in patients with moderate-severe Crohn's disease in a global setting
    Dignass, A.
    Joshi, N.
    Lukanova, R.
    Dawod, F.
    Jones, W.
    Kligys, K.
    Zambrano, J. A.
    Song, A.
    Griffith, J.
    Jairath, V
    Bossuyt, P.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i388 - i390
12345